Genital Diseases, Female  >>  Proleukin (aldesleukin)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Proleukin (aldesleukin) / Merck (MSD), Novartis, Iovance Biotherap
NCT00019136: Gene Therapy and Biological Therapy in Treating Patients With Ovarian Epithelial Cancer

Completed
1
US
MOv-gamma chimeric receptor gene, aldesleukin, therapeutic allogeneic lymphocytes
National Cancer Institute (NCI)
Ovarian Cancer
 
 
NCT02482090 / 2015-000530-30: TIL Therapy for Metastatic Ovarian Cancer

Completed
1
6
Europe
Cyclophosphamide, Cyclophospamide, Fludarabine, Fludarabinephosphate, Fludara, TIL infusion, T Cell infusion, Interleukin-2, IL-2, Proleukin
Inge Marie Svane
Metastatic Ovarian Cancer
12/16
04/17

Download Options